{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:15:04Z","timestamp":1790828104939,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","arthroplastyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.arth.2024.05.025","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T06:28:27Z","timestamp":1715754507000},"page":"S212-S217.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S2","title":["Trends in Venous Thromboembolism and Chemoprophylaxis Utilization in Elective Total Knee Arthroplasty From 2011 to 2020"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8798-5521","authenticated-orcid":false,"given":"Anthony K.","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amil R.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nauman","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savyasachi C.","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Golladay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2024.05.025_bib1","first-page":"65","article-title":"Total knee replacement and imaging","volume":"87","author":"Scott","year":"2015","journal-title":"Radiol Technol"},{"key":"10.1016\/j.arth.2024.05.025_bib2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/medicina56090416","article-title":"An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020","volume":"56","author":"Santana","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.arth.2024.05.025_bib3","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJM199311043291902","article-title":"A\u00a0comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation","volume":"329","author":"Hull","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2024.05.025_bib4","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.arth.2024.05.025_bib5","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1111\/bcp.14833","article-title":"Drug-drug interactions with warfarin: a systematic review and meta-analysis","volume":"87","author":"Wang","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.arth.2024.05.025_bib6","first-page":"295","article-title":"Deep venous thrombosis and pulmonary embolism: current therapy","volume":"95","author":"Wilbur","year":"2017","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.arth.2024.05.025_bib7","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism","volume":"2","author":"van Den Belt","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.arth.2024.05.025_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1712746","article-title":"Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty","volume":"378","author":"Anderson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.arth.2024.05.025_bib9","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.2106\/JBJS.I.00511","article-title":"American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty","volume":"91","author":"Johanson","year":"2009","journal-title":"J\u00a0Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2024.05.025_bib10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s11999-014-3559-0","article-title":"Nationwide inpatient sample and national surgical quality improvement Program give different results in hip fracture studies","volume":"472","author":"Bohl","year":"2014","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2024.05.025_bib11","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.arth.2019.04.027","article-title":"Trends in length of stay and 30-day complications after total knee arthroplasty: an analysis from 2006 to 2016","volume":"34","author":"Sarpong","year":"2019","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2024.05.025_bib12","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1016\/j.arth.2017.06.039","article-title":"Impact of definition and timeframe on capturing surgery-related readmissions after primary joint arthroplasty","volume":"32","author":"Chen","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2024.05.025_bib13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.arth.2016.10.020","article-title":"The incidence and economic burden of in-hospital venous thromboembolism in the United States","volume":"32","author":"Shahi","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2024.05.025_bib14","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1016\/j.arth.2017.06.041","article-title":"Persistent pulmonary embolism rates following total knee arthroplasty even with prophylactic anticoagulants","volume":"32","author":"Cote","year":"2017","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2024.05.025_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.arth.2020.07.059","article-title":"More patients are being discharged home after total knee arthroplasty, however rates vary between large databases","volume":"36","author":"DeMik","year":"2021","journal-title":"J\u00a0Arthroplasty"},{"key":"10.1016\/j.arth.2024.05.025_bib16","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11999-017-5394-6","article-title":"Venous thromboembolism prophylaxis after TKA: aspirin, warfarin, enoxaparin, or factor Xa inhibitors?","volume":"475","author":"Bala","year":"2017","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.arth.2024.05.025_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5435\/JAAOS-D-17-00235","article-title":"Trends in deep vein thrombosis prophylaxis and deep vein thrombosis rates after total hip and knee arthroplasty","volume":"26","author":"Bawa","year":"2018","journal-title":"J\u00a0Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2024.05.025_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.arth.2018.12.015","article-title":"Utilization patterns, efficacy, and complications of venous thromboembolism prophylaxis strategies in primary hip and knee arthroplasty as reported by American board of orthopedic surgery Part II candidates","volume":"34","author":"Runner","year":"2019","journal-title":"J\u00a0Arthroplasty"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540324004583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540324004583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T11:52:56Z","timestamp":1725450776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540324004583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0883540324004583"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2024.05.025","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in Venous Thromboembolism and Chemoprophylaxis Utilization in Elective Total Knee Arthroplasty From 2011 to 2020","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2024.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}